Immix Biopharma Inc. (IMMX) - Rasio kapitalisasi marang bathi resik

The confirmed price history on this chart helps assess the resilience of Immix Biopharma, Inc. (IMMX), which is developing immune-based methods for combating tumors. The business relies on patent protection and is navigating stringent FDA oversight, with the indicator standing at -14.10. Research accuracy is ensured by strict adherence to temperature controls during the transport of biomaterials. The current share price already prices in R&D costs and the risks associated with small-cap companies ahead of the launch of new trials.

IMMX immixbio.com: Koefisien rega marang bathi ing interval 22.08.2022 - 14.11.2026

Rincian analitis perusahaan Immix Biopharma, Inc.

- rega pasar lan target rega analis:

Rega bursa Immix|IMMX - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Kapitalisasi pasar Immix Biopharma, Inc.|IMMX - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Aset Bersih saben Saham Immix Biopharma|IMMX - Aset Bersih Perusahaan|Nilai Pasar marang Nilai Buku immixbio.com|IMMX - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Koefisien Total Utang marang Modal Immix Biopharma, Inc.|IMMX - Utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Immix|IMMX - Utang perusahaan|Utang marang nilai buku Immix Biopharma, Inc.|IMMX - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Immix Biopharma|Rasio likuiditas darurat immixbio.com

- data bathi bisnis lan rasio investasi:

IMMX - Bathi resik perusahaan|Bathi resik sing dikarepake Immix Biopharma, Inc.|IMMX - Koefisien rega marang bathi|Pangali forward rega marang bathi Immix|IMMX - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Immix Biopharma, Inc.|IMMX - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Immix Biopharma|IMMX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan immixbio.com|IMMX - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Immix Biopharma, Inc.

- rincian pendapatan lan dodolan emiten:

IMMX - Pendapatan lan volume dodolan|Prakiraan volume dodolan Immix|IMMX - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan Immix Biopharma, Inc.

Analisis komprehensif perusahaan:IMMX immixbio.com

Produk asil prodhuksi Immix Biopharma, Inc.

To minimize risks when building a position, it is essential to monitor the company's price-to-earnings ratio, which measures market capitalization relative to annual net income. For Immix Biopharma, Inc. (IMMX), which develops breakthrough methods for combating tumors, this indicator reflects the balance between immunotherapy investments and actual business efficiency, confirming the developer's fundamental stability.

Perusahaan pesaing